These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8112244)

  • 1. Acute oral loading of carbamazepine-CR and phenytoin in a double-blind randomized study of patients at risk of seizures.
    Van Der Meyden CH; Kruger AJ; Müller FO; Rabie W; Schall R
    Epilepsia; 1994; 35(1):189-94. PubMed ID: 8112244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication.
    Zielinski JJ; Haidukewych D; Leheta BJ
    Ther Drug Monit; 1985; 7(1):51-3. PubMed ID: 3992622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual effects of carbamazepine-phenytoin interaction.
    Zielinski JJ; Haidukewych D
    Ther Drug Monit; 1987; 9(1):21-3. PubMed ID: 3576659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of discontinuation of phenytoin, carbamazepine, and valproate on concomitant antiepileptic medication.
    Duncan JS; Patsalos PN; Shorvon SD
    Epilepsia; 1991; 32(1):101-15. PubMed ID: 1985818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of carbamazepine or phenytoin therapy on blood level of intravenously administered midazolam: a prospective cohort study.
    Hayashi T; Higuchi H; Tomoyasu Y; Ishii-Maruhama M; Maeda S; Miyawaki T
    J Anesth; 2016 Feb; 30(1):166-9. PubMed ID: 26272251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
    Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
    Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice.
    Wlaź P; Roliński Z; Czuczwar SJ
    Epilepsia; 1996 Jul; 37(7):610-7. PubMed ID: 8681892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
    Graves NM; Holmes GB; Fuerst RH; Leppik IE
    Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy.
    Epilepsia; 1998 Sep; 39(9):952-9. PubMed ID: 9738674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiagabine versus phenytoin and carbamazepine as add-on therapies: effects on abilities, adjustment, and mood.
    Dodrill CB; Arnett JL; Deaton R; Lenz GT; Sommerville KW
    Epilepsy Res; 2000 Dec; 42(2-3):123-32. PubMed ID: 11074185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patients.
    McKee PJ; Blacklaw J; Butler E; Gillham RA; Brodie MJ
    Br J Clin Pharmacol; 1991 Jul; 32(1):99-104. PubMed ID: 1888646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate and zonisamide prevent paradoxical intoxication induced by carbamazepine and phenytoin.
    Yamamura S; Hamaguchi T; Ohoyama K; Sugiura Y; Suzuki D; Kanehara S; Nakagawa M; Motomura E; Matsumoto T; Tanii H; Shiroyama T; Okada M
    Epilepsy Res; 2009 Apr; 84(2-3):172-86. PubMed ID: 19268540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
    McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of phenobarbital and phenytoin with carbamazepine and its metabolites' concentrations, concentration ratios, and level/dose ratios in epileptic children.
    Liu H; Delgado MR
    Epilepsia; 1995 Mar; 36(3):249-54. PubMed ID: 7614908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy.
    Garnett WR; Levy B; McLean AM; Zhang Y; Couch RA; Rudnic EM; Pellock JM; Belendiuk GW
    Epilepsia; 1998 Mar; 39(3):274-9. PubMed ID: 9578044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of single- and multiple-dose carbamazepine on the pharmacokinetics of diphenylhydantoin.
    Lai ML; Lin TS; Huang JD
    Eur J Clin Pharmacol; 1992; 43(2):201-3. PubMed ID: 1425879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of carbamazepine and phenytoin in pregnancy.
    Tomson T; Lindbom U; Ekqvist B; Sundqvist A
    Epilepsia; 1994; 35(1):131-5. PubMed ID: 8112235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.
    Fagiolino P; Vázquez M; Maldonado C; Ruiz ME; Volonté MG; Orozco-Suárez S; Lazarowski A
    Curr Pharm Des; 2013; 19(38):6701-8. PubMed ID: 23530513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily fluctuation of plasma levels with conventional and controlled-release carbamazepine: correlation with adverse effects.
    Bareggi SR; Tata MR; Guizzaro A; Pirola R; Parisi A; Monza CG
    Int Clin Psychopharmacol; 1994; 9(1):9-16. PubMed ID: 8195585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of conventional and controlled-release carbamazepine in healthy subjects.
    Larkin JG; McLellan A; Munday A; Sutherland M; Butler E; Brodie MJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):313-22. PubMed ID: 2655682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.